Hui Wang

Director/Board Member at Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.

Net worth: 83 565 $ as of 29/04/2024

53 year

Consumer Non-Durables

Health Technology

Profile

Hui Wang is currently working as an Executive Director & Manager at Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Prior to this, Mr. Wang worked as a Director at CSPC Innovation Pharmaceutical Co., Ltd.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CSPC INNOVATION PHARMACEUTICAL CO., LTD. 0.01%	29/09/2023	17,658 ( 0.01% )	83 565 $	29/04/2024

Hui Wang active positions

Companies	Position	Start
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million.	Director/Board Member	-

All active positions of Hui Wang

Former positions of Hui Wang

Companies	Position	End
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	Director/Board Member	11/04/2023

See the detail of Hui Wang's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hui Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	Consumer Non-Durables

Private companies	1
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million.	Health Technology